What type of kidney stone is associated with a urine pH of 5.5?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Kidney Stones Associated with Urine pH 5.5

At a urine pH of 5.5, uric acid stones are the most likely type of kidney stone to form, as this acidic environment significantly reduces uric acid solubility and promotes crystallization. 1, 2

Pathophysiology of Uric Acid Stone Formation at pH 5.5

Uric acid has a pKa of 5.4-5.7, making it poorly soluble in water at acidic pH levels. At a urine pH of approximately 5.5:

  • Uric acid solubility is dramatically reduced to approximately 15 mg/dL 1
  • Undissociated uric acid predominates, promoting crystal formation and precipitation 2
  • The precipitation of uric acid in renal tubules can lead to stone formation and potential renal insufficiency 1

Evidence Supporting Uric Acid Stones at pH 5.5

Research clearly demonstrates the relationship between acidic urine and uric acid stone formation:

  • A retrospective study of 1,478 patients found that 50.9% of uric acid-related calcium oxalate monohydrate unattached calculi were present in patients with urinary pH <5.5 2
  • The solubility of uric acid increases dramatically from 15 mg/dL at pH 5.0 to approximately 200 mg/dL at pH 7.0 1
  • Urine with pH <5.5 shows an increased capacity to develop uric acid crystals, which can also act as heterogeneous nuclei for calcium oxalate crystal formation 2

Clinical Implications and Management

For patients with urine pH of 5.5 and uric acid stones:

First-line Treatment:

  • Urinary alkalinization with potassium citrate is the cornerstone of treatment to increase urine pH to approximately 6.0 1
  • Potassium citrate is preferred over sodium citrate as the sodium load in the latter may increase urine calcium excretion 1

Dosing:

  • Initial potassium citrate dosage: 30-60 mEq/day based on severity of the condition 3
  • Maximum dose should not exceed 100 mEq/day 3
  • Should be taken with meals or within 30 minutes after meals 3

Monitoring:

  • 24-hour urine collection within 6 months of initiating treatment 3
  • Annual 24-hour urine specimens to assess adherence and metabolic response 3
  • Monitor serum electrolytes, creatinine, and complete blood counts every four months 3

Important Cautions:

  • Allopurinol should not be used as first-line therapy for uric acid stones 1
  • Most patients with uric acid stones have low urinary pH rather than hyperuricosuria as the predominant risk factor 1

Lifestyle Modifications

  • Increase fluid intake to achieve urine output of at least 2-2.5 liters per day 3, 4
  • Limit sodium intake to less than 2,300 mg daily 3
  • Maintain normal calcium intake (1,000-1,200 mg daily) 3
  • Consider moderate restriction of animal protein 3, 4
  • Avoid soft drinks acidified with phosphoric acid (colas) and sugar-sweetened beverages 3

Differential Considerations

While uric acid stones are most common at pH 5.5, it's important to note that:

  • Calcium oxalate stones can form at any urinary pH, but at pH 5.5, they often form on uric acid crystal nuclei 2
  • Calcium phosphate stones typically form at higher urinary pH (>6.0) 2
  • Struvite (magnesium ammonium phosphate) stones form in alkaline urine (pH >7.2) associated with urease-producing bacterial infections 1

By addressing the acidic urinary environment through alkalinization therapy and appropriate lifestyle modifications, the risk of uric acid stone formation and recurrence can be significantly reduced.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Urinary pH and renal lithiasis.

Urological research, 2012

Guideline

Management of Type 4 Renal Tubular Acidosis (RTA) with Kidney Stones

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Kidney Stone Prevention.

Advances in nutrition (Bethesda, Md.), 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.